Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ASCL5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TIFAB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TSSK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GOLGA8R | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CORO2B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CFAP77 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SSB | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NINJ2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | AL356053.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | UBLCP1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |